| Bioactivity | Eldacimibe is an ACAT2 inhibitor. Eldacimibe can lower plasma cholesterol levels by blocking cholesterol absorption and can prevent macrophages from turning into foam cells. Eldacimibe can be used in the study of cardiovascular diseases (atherosclerosis), endocrine and metabolic diseases (hypercholesterolemia) [1]. |
| CAS | 141993-70-6 |
| Formula | C39H58N2O5 |
| Molar Mass | 634.89 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Chhabria M T, et al. Update on patented cholesterol absorption inhibitors[J]. Expert Opinion on Therapeutic Patents, 2009, 19(8): 1083-1107. |
Eldacimibe
CAS: 141993-70-6 F: C39H58N2O5 W: 634.89
Eldacimibe is an ACAT2 inhibitor. Eldacimibe can lower plasma cholesterol levels by blocking cholesterol absorption and
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.